ABCC1 is a 190 kDa protein containing two hydrophobic transmembrane domains and two nucleotide-binding domains. Each transmembrane domain consists of six α-helices. The protein encoded by the ABCC1 gene is a member of the ATP-binding cassette (ABC) transporter superfamily. In addition, the protein contains a third transmembrane domain that distinguishes it from other transporters in the ATP-binding cassette transporter family. ABC proteins transport various molecules across the outer and inner cell membranes. This integral transporter is a member of the MRP subfamily, which has been implicated in multidrug resistance. Because ABCC1 is able to transport many chemotherapeutic drugs out of cells, it plays a role in the multidrug resistance of cancerous tumor cells. CD ComputaBio now offers professional ABCC1 targeting services to meet your research needs.
Our Services
- ABCC1 Inhibitor Design Services
The ABCC1 transporter is particularly prevalent in neuroblastoma and cancer cells found in the lung, breast, and prostate. In non-small cell lung cancer and small cell lung cancer, high expression of ABCC1 indicates decreased response to chemotherapeutic drugs and decreased survival. Therefore, we provide professional ABCC1 inhibitor services, our experts have accumulated years of experience in small molecule design, and can provide you with a one-stop solution.
- Pathway and Network Analysis
CD ComputaBio provides comprehensive services for network analysis. We will construct a signaling pathway regulatory network based on the mutual regulatory relationship between the pathways in which all differential genes are simultaneously involved, and study the signal transduction and regulatory processes between various signaling pathways from a systematic perspective. We can discover core pathways and regulatory mechanisms in important signaling pathways that are affected by experiments.
- Virtual Screening Service
The Virtual Screening (VS) service is active compound screening based on small molecule databases. Our virtual screening service can rapidly screen tens of millions to millions of molecules of druggable active compounds, greatly reducing the number of experimentally screened compounds and shortening research time. There are two main types of virtual screening methods: structure-based virtual screening (SBVS) and ligand-based virtual screening (LBVS).
Our Capabilities
CD ComputaBio provides corresponding ABCC1 targeting services. Our computational services provide accurate approximations of real molecular behavior and have proven useful for understanding the biochemical basis of physiological events at different stages of drug development. Our team of experts can provide up to a millisecond of simulation time for the system of your choice, so you don't have to worry about technical issues.
Our Molecular Docking Strategies Targeting ABCC1
Molecular docking is a method for drug design based on the characteristics of receptors and the interaction between receptors and drug molecules. It is a theoretical simulation method that mainly studies the interactions between molecules (such as ligands and receptors) and predicts their binding modes and affinities. In recent years, molecular docking methods have become an important technology in the field of computer-aided drug research. Our molecular docking service process includes：
- Structural preparation before docking, including: receptor structures and small molecule compounds (libraries)
- Molecular docking calculations, including: conformational search and scoring evaluation
- Results analysis, including: docking conformation or seedling compound selection, binding mode analysis, scoring and stress analysis, etc.
* For Research Use Only.
